Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
331
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Samsung Biologics
•
05 Oct 2016 05:19
Samsung BioLogics IPO Part 2 - Financials
Samsung BioLogics has just filed an IPO report. I will summarize Samsung BioLogics IPO report in the following three parts:Part 1 - IPO...
Sanghyun Park
Follow
138 Views
Share
bearish
•
Samsung Biologics
•
04 Oct 2016 23:11
Samsung BioLogics IPO Part 1 - IPO Proceeding
Samsung BioLogics has just filed an IPO report. I will summarize Samsung BioLogics IPO report in the following three parts:Part 1 - IPO...
Sanghyun Park
Follow
223 Views
Share
bearish
•
Samsung Biologics
•
04 Oct 2016 07:43
Samsung BioLogics IPO Price, Capital Investment Plan & Valuation Issue
In a regulatory filing (last Friday), Samsung Biologics announced its plan to raise ₩1.23tril (US$1.12bil) of new shares. Samsung BioLogics plans...
Sanghyun Park
Follow
279 Views
Share
bearish
•
Celltrion Inc
•
16 Sep 2016 06:18
More Harsh Reality from Teva
U.S. healthcare industry leaders from across the spectrum of industry segments continue to downplay the near-term adoption of biosimilars in the...
Kemp Dolliver, CFA
198 Views
Share
bearish
•
Samsung Biologics
•
20 Aug 2016 22:28
US$9 Billion Valuation Is Rarefied Air
Samsung's proposed ~US$9 billion valuation for Samsung BioLogics would out the latter in a very select company: a US$9 billion market cap for a...
Kemp Dolliver, CFA
247 Views
Share
First
Previous
61
62
63
64
65
66
67
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x